Today

Agents

Chat

Arena

Discover

More

App

Biocryst Pharmaceuticals: JP Morgan raises target price to $13 from $12

BCRX•2026-09-30

JP Morgan raised its target price for Biocryst Pharmaceuticals to $13 from $12.

Related News

D

Soybeans ease ahead of USDA stocks report, tariff cuts exclude soy

DBA•2026-09-30

Oric Pharma CFO Dominic Piscitelli disposes of 13,400 common shares worth $181,257.78

ORIC•2026-09-29

Amplitude, Inc.: Piper Sandler raises target price to $18 from $13

AMPL•2026-09-30

Exponent hosts investor day at Phoenix test and engineering center

EXPO•2026-09-30

Boeing wins US Navy's next-generation fighter contract, Pentagon says

BA•2026-09-30

Biocryst Pharmaceuticals: JP Morgan raises target price to $13 from $12 - BCRX News | Rallies